In a world where communication about health, technology, and business is taking place on platforms for real-time conversations with many different audiences, at Mauna Kea Technologies we have decided it’s time to take an important new step in our ongoing commitment to keeping you informed about our progress in delivering the benefits of Cellvizio to patients and clinicians around the world. This new blog is an opportunity for us to provide perspectives on our business strategy and progress.
In the coming months we’ll provide updates on clinical research and publications that support our mission to position optical biopsy as the standard of care in multiple therapeutic areas and indications in the years ahead. We’ll share many of the compelling case studies that show how cutting-edge imaging technology is bringing the smallest microscope in the world to the patient, with critical benefits including real-time evaluation of tissue with immediate diagnostic results to support faster and more effective intervention. We’ll also post content developed by clinicians from around the world who share their perspectives with us, and we’ll give you additional insights about our news to show how important developments fuel our growth.